Intervention

8 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
afinitor	Novartis AG (NVS)
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
fenofibrate	ANI PHARMACEUTICALS INC (ANIP)
liberty endovascular robotic surgical system	Microbot Medical Inc. (MBOT)
prasugrel	Mylan II B.V. (MYL)
XIENCE® family of drug-eluting coronary stent systems	ABBOTT LABORATORIES (ABT)

Phase 3(1)

Drug	Company
angiomax	SCICLONE PHARMACEUTICALS INC (SCLN)

Unknown(1)

Drug	Company
Prolaris	MYRIAD GENETICS INC (MYGN)

BioSniper tracks 8 drugs in development for Intervention across 8 companies.

There are 1 clinical trial targeting Intervention tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.